CASP1 and Alzheimer disease: Previous studies have also demonstrated that caspase-1 activation and subsequent GSDMD cleavage play key roles in pyroptosis and neuroinflammation in CNS diseases, such as cerebral ischemia and AD, and that the inhibition of caspase-1 activation can attenuate brain injury [36–38].